Dr. Mark D. Suski, MD

Dr. Suski practices at Los Robles Surgicenter - HOPD in Thousand Oaks, California.

Dr. Suski's NPI, 1093886731, was assigned on November 13, 2006. Dr. Suski graduated from Georgetown University School Of Medicine in 1991. Dr. Suski holds California license G76464.

Dr. Suski's primary practice is Los Robles Surgicenter - HOPD, at 2190 Lynn Rd, Thousand Oaks, CA 91360.

Dr. Suski's primary practice is Los Robles Surgicenter - HOPD in Thousand Oaks, California. Dr. Suski is also affiliated with Los Robles Regional Medical Center. Dmand AI also links Dr. Suski to 2 more home health agencies, 1 physician office and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Suski practices, 6 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Suski's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Suski is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Suski's licenses on file in 2 states: California and New York.

Dmand AI lists cancerous skin growth removal, chronic skin ulcer, head wound, lymphedema and removal of damaged skin or skin graft among the conditions Dr. Suski treats.

CMS data shows 1,534 Medicare services from Dr. Suski across 8 procedure codes in 2024, for 381 Medicare patients. Medicare paid $130,887 for them.

CMS counts 381 Medicare patients who saw Dr. Suski in 2024. The largest group is 75 to 84, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Suski's median patient age at 76, with 58% women.

In 2024, Dr. Suski wrote 284 Medicare Part D claims for 188 patients. 90% of them were for generic drugs. CMS names the drug for 247 of them, across 6 drugs with 11 or more claims each, at $7,069 in total drug cost. In 2023, CMS named 177 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 65 out of 100 for Dr. Suski for performance year 2024, reported individually. Dr. Suski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of melanoma (skin cancer) excision by Dr. Suski, more than 85% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Suski. The most frequent topics are Negative-Pressure Wound Therapy, Wound Healing and Wounds and Injuries. Dr. Suski has published most often in Wounds. Dr. Suski's most frequent co-authors are Michael N. Desvigne, MD, William Harmon Tettelbach, MD and Abigail E. Chaffin, MD.

CMS Open Payments shows 357 general payments to Dr. Suski from 36 drug and device companies from 2016 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 50% of the total. Kerecis Limited paid the most, $242,814. It also lists 2 research payments totaling $2,500 in 2025.

Dmand AI lists 1 award for Dr. Suski.

Dr. Suski graduated from Georgetown University School Of Medicine in 1991. Dr. Suski is a member of ACS and ASPS.

Dr. Suski is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.